Infections after liver transplantation. An analysis of 101 consecutive cases.

PubWeight™: 5.77‹?› | Rank: Top 1%

🔗 View Article (PMC 2979316)

Published in Medicine (Baltimore) on March 01, 1988


S Kusne1, J S Dummer, N Singh, S Iwatsuki, L Makowka, C Esquivel, A G Tzakis, T E Starzl, M Ho

Author Affiliations

1: Department of Medicine, School of Medicine, University of Pittsburgh, PA 15261.

Articles citing this

Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86

Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75

Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients. J Clin Microbiol (1991) 1.69

A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation. Transplant Proc (1991) 1.40

Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33

Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc (1990) 1.30

Transplantation in HIV+ patients. Transplantation (1990) 1.29

Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis (1997) 1.25

Infectious complications after small bowel transplantation in adults. Transplant Proc (1994) 1.24

Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. Ann Thorac Surg (1992) 1.18

The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. Transplant Proc (1991) 1.16

Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis (1992) 1.12

OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11

CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry (1993) 1.07

Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl (2011) 1.06

The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc (1991) 1.05

Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J (2009) 1.04

Update and actual trends on bacterial infections following liver transplantation. World J Gastroenterol (2008) 1.00

A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. J Thorac Cardiovasc Surg (1993) 1.00

Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. Rev Infect Dis (1991) 0.99

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I). J Transl Med (2011) 0.97

Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg (1996) 0.96

Pediatric lung transplantation. The years 1985 to 1992 and the clinical trial of FK 506. J Thorac Cardiovasc Surg (1993) 0.96

The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation. Transplant Proc (1991) 0.94

Bacterial infection after liver transplantation. World J Gastroenterol (2014) 0.94

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation (1994) 0.93

Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc (1993) 0.90

Perioperative bacterial infections in deceased donor and living donor liver transplant recipients. J Clin Exp Hepatol (2012) 0.90

Neuropathologic findings after liver transplantation. Acta Neuropathol (1992) 0.90

Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression. Eur J Clin Microbiol Infect Dis (1997) 0.87

Liver transplantation. Experience with 100 cases. West J Med (1991) 0.86

Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev (1997) 0.85

Candida carriage in the alimentary tract of liver transplant candidates. Transplantation (1994) 0.84

Resveratrol prolongs allograft survival after liver transplantation in rats. World J Gastroenterol (2005) 0.83

A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg (1996) 0.83

Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection. Ther Clin Risk Manag (2015) 0.83

Clinical use of selective decontamination: the concept. Intensive Care Med (1990) 0.82

Fungal infections complicating orthotopic liver transplantation. Trans Am Clin Climatol Assoc (1995) 0.80

Infectious complications after small bowel transplantation in adults: an update. Transplant Proc (1996) 0.80

Concentrations in plasma and tissue penetration of ceftriaxone and ornidazole during liver transplantation. Antimicrob Agents Chemother (1993) 0.80

Bloodstream infections after solid-organ transplantation. Virulence (2016) 0.79

Risk factors for liver rejection: evidence to suggest enhanced allograft tolerance in infancy. Arch Dis Child (1996) 0.79

Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. Transplant Proc (1992) 0.79

Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. Transplantation (1992) 0.78

Study protocol: a pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. PATRON-study. BMC Nephrol (2010) 0.78

Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge. World J Gastroenterol (2014) 0.78

Liver transplantation(). J Ultrasound (2007) 0.77

Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias. Eur J Clin Microbiol Infect Dis (2014) 0.77

Sterility of bile in multiple-organ donors. Transplantation (1990) 0.76

Haemophilus parainfluenzae liver abscess after successful liver transplantation. J Clin Microbiol (1998) 0.76

Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc (1991) 0.76

Infections after liver transplantation: risk factors and prevention. Transplant Proc (1991) 0.76

Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial. Trials (2014) 0.75

Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia. BMC Infect Dis (2017) 0.75

Predictors of mortality in solid-organ transplant recipients with infections caused by Acinetobacter baumannii. Ther Clin Risk Manag (2015) 0.75

CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc (1991) 0.75

Gangrene of the anterior abdominal wall after orthotopic liver transplantation: invasive cutaneous candidiasis. Postgrad Med J (1993) 0.75

Atypical oral presentation of herpes simplex virus infection in a patient after orthotopic liver transplantation. Eur Arch Otorhinolaryngol (1994) 0.75

Microbiological efficacy and pharmacokinetics of prophylactic antibiotics in liver transplant patients. Antimicrob Agents Chemother (1992) 0.75

Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? Dig Dis Sci (1994) 0.75

Sinonasal evaluation and treatment before liver transplantation: a retrospective review of 982 patients. Eur Arch Otorhinolaryngol (2014) 0.75

Articles cited by this

Evolution of liver transplantation. Hepatology (1982) 19.54

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60

A five-year prospective study of 23,649 surgical wounds. Arch Surg (1973) 3.22

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Infections in recipients of liver homografts. N Engl J Med (1968) 1.92

Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation. Transplantation (1985) 1.90

Fungus infections after liver transplantation. Ann Surg (1977) 1.81

Incidence of wound infection on the surgical services. Surg Clin North Am (1975) 1.54

Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50

Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med (1982) 1.44

Rapid diagnosis of candidiasis and aspergillosis. Rev Infect Dis (1987) 1.41

Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med (1987) 1.38

Liver transplantation today. Ann Intern Med (1986) 1.34

Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis (1984) 1.29

The development of biliary "sludge" following liver transplantation. Transplant Proc (1979) 1.14

Risk factors in the development of cytomegalovirus-related pneumonia in renal transplant recipients. J Infect Dis (1983) 1.13

Clinical development of Orthoclone OKT3. Transplant Proc (1987) 1.05

Self-limited Toxoplasma parasitemia after liver transplantation. Transplantation (1987) 0.94

Articles by these authors

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10

Evolution of liver transplantation. Hepatology (1982) 19.54

A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet (1997) 10.93

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science (1997) 6.00

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73


Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut (2002) 3.73

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A (1970) 3.66

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48


The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med (2001) 3.39

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med (1992) 3.30

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22